Abstract
Aberrant biochemical processes in the brain frequently go along with subtle shifts of the cellular epigenetic profile that might support the pathogenic progression of psychiatric disorders. Although recent reports have implied the ability of certain antidepressants and mood stabilizers to modulate epigenetic parameters, studies comparing the actions of these compounds under the same conditions are lacking. In this study, we screened amitriptyline (AMI), venlafaxine, citalopram, as well as valproic acid (VPA), carbamazepine, and lamotrigine for their potential actions on global and local epigenetic modifications in rat primary astrocytes. Among all drugs, VPA exposure evoked the strongest global chromatin modifications, including histone H3/H4 hyperacetylation, 2MeH3K9 hypomethylation, and DNA demethylation, as determined by western blot and luminometric methylation analysis, respectively. CpG demethylation occurred independently of DNA methyltransferase (DNMT) suppression. Strikingly, AMI also induced slight cytosine demethylation, paralleled by the reduction in DNMT enzymatic activity, without affecting the global histone acetylation status. Locally, VPA-induced chromatin modifications were reflected at the glutamate transporter (GLT-1) promoter as shown by bisulfite sequencing and acetylated histone H4 chromatin immunoprecipitation analysis. Distinct CpG sites in the distal part of the GLT-1 promoter were demethylated and enriched in acetylated histone H4 in response to VPA. For the first time, we could show that these changes were associated with an enhanced transcription of this astrocyte-specific gene. In contrast, AMI failed to stimulate GLT-1 transcription and to alter promoter methylation levels. In conclusion, VPA and AMI globally exerted chromatin-modulating activities using different mechanisms that divergently precipitated at an astroglial gene locus.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Allritz C, Bette S, Figiel M, Engele J (2009). Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. Neurochem Int 55: 22–27.
Azmitia EC (2001). Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56: 413–424.
Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, Handa V et al (2007). Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671–675.
Beutler AS, Li SD, Nicol R, Walsh MJ (2005). Carbamazepine is an inhibitor of histone deacetylases. Life Sci 76: 3107–3115.
Brunk BP, Goldhamer DJ, Emerson CP (1996). Regulated demethylation of the MyoD distal enhancer during skeletal myogenesis. Develop Biol 177: 490–503.
Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB et al (2006). Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70: 487–492.
Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC et al (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatr 11: 1116–1125.
Chen WG, Chang Q, Lin YX, Meissner A, West AE, Griffith EC et al (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885–889.
Chikhirzhina GI, Al-Shekhadat RI, Chikhirzhina EV (2008). Transcription factors of the NF1 family: role in chromatin remodeling. Mol Biol 42: 342–356.
Choi DW (1988). Glutamate neurotoxicity and diseases of the nervous-system. Neuron 1: 623–634.
Cotter D, MacKay D, Landau S, Kerwin R, Everall I (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatr 58: 545–553.
Czeh B, Simon M, Schmelting B, Hiemke C, Fuchs E (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31: 1616–1626.
D'Alessio AC, Szyf M (2006). Epigenetic tete-a-tete: the bilateral relationship between chromatin modifications and dna methylation. Biochem Cell Biol-Biochim Biol Cell 84: 463–476.
Detich N, Bovenzi V, Szyf M (2003). Valproate induces replication-independent active DNA demethylation. J Biol Chem 278: 27586–27592.
Dong E, Guidotti A, Grayson DR, Costa E (2007). Histone hyperacetylation induces demethylation of reelin and 67-KDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci USA 104: 4676–4681.
Eyal S, Yagen B, Sobol E, Altschuler Y, Shmuel M, Bialer M (2004). The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 45: 737–744.
Fazzari MJ, Greally JM (2004). Epigenomics: beyond CpG islands. Nat Rev Genet 5: 446–455.
Fischer A, Sananbenesi F, Wang XY, Dobbin M, Tsai LH (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature 447: 178–1U2.
Franke B, Figiel M, Engele J (1998). CNS glia are targets for GDNF and Neurturin. Histochem Cell Biol 110: 595–601.
Fuks F, Hurd PJ, Deplus R, Kouzarides T (2003). The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305–2312.
Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S et al (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969–6978.
Guardiola AR, Yao TP (2002). Molecular cloning and characterization of a novel histone deacetylase HDAC10. J Biol Chem 277: 3350–3356.
Gurvich N, Tsygankova OM, Meinkoth JL, Kein PS (2004). Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 64: 1079–1086.
Hashimoto K, Sawa A, Iyo M (2007). Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatr 62: 1310–1316.
Hassel B, Iversen EG, Gjerstad L, Tauboll E (2001). Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate. J Neurochem 77: 1285–1292.
Hauke J, Riessland M, Lunke S, Eyupoglu IY, Blumcke I, El-Osta A et al (2009). Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 18: 304–317.
Herman JG, Baylin SB (2003). Mechanisms of disease: gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042–2054.
Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP et al (2007). Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27: 11254–11262.
Inazu M, Takeda H, Ikoshi H, Sugiswa M, Uchida Y, Matsumiya T (2001). Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem Int 39: 39–49.
Inazu M, Takeda H, Matsumiya T (2003). Functional expression of the norepinephrine transporter in cultured Rat astrocytes. J Neurochem 84: 136–144.
Javitt DC (2004). Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatr 9: 984–997.
Karimi M, Johansson S, Stach D, Corcoran M, Grander D, Schalling M et al (2006). LUMA (LUminometric Methylation Assay) – a high throughput method to the analysis of genomic DNA methylation. Exp Cell Res 312: 1989–1995.
Ko ER, Ko D, Chen C, Lipsick JS (2008). A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding. Mol Cancer 7: 77.
Kundakovic M, Chen Y, Guidotti A, Grayson DR (2009). The Reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75: 342–354.
Lachner M, Jenuwein T (2002). The many faces of histone lysine methylation. Curr Opin Cell Biol 14: 286–298.
Manev H, Uz T, Manev R (2003). Glia as a putative target for antidepressant treatments. J Affect Disord 75: 59–64.
McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M et al (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12: 342–348.
McGowan PO, Sasaki A, Huang TC, Unterberger A, Suderman M, Ernst C et al (2008). Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE 3: e2085.
Mill J, Petronis A (2007). Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatr 12: 799–814.
Ng HH, Bird A (1999). DNA methylation and chromatin modification. Curr Opin Genet Develop 9: 158–163.
Ou JN, Torrisani J, Unterberger A, Provencal N, Shikimi K, Karimi M et al (2007). Histone deacetylase inhibitor trichostatin a induces global and gene-specific DNA demethylation in human cancer cell lines. Biochem Pharmacol 73: 1297–1307.
Pavone A, Cardile T (2003). An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 44: 34–39.
Petronis A (2003). Epigenetics and bipolar disorder: new opportunities and challenges. Am J Med Genet Part C-Semin Med Genet 123C: 65–75.
Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734–36741.
Poulter MO, Du LS, Weaver ICG, Palkovits M, Faludi G, Merali Z et al (2008). GABA(A) receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatr 64: 645–652.
Rajkowska G, Miguel-Hidalgo JJ, Wei JR, Dilley G, Pittman SD, Meltzer HY et al (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatr 45: 1085–1098.
Roopra A, Qazi R, Schoenike B, Daley TJ, Morrison JF (2004). Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14: 727–738.
Rothstein JD, DykesHoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW et al (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675–686.
Schipke CG, Kettenmann H (2004). Astrocyte responses to neuronal activity. Glia 47: 226–232.
Schousboe A, Waagepetersen HS (2006). Glial modulation of GABAergic and glutamat Ergic neurotransmission. Curr Topics Med Chem 6: 929–934.
Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007). Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatr 62: 55–64.
Sharma RP, Tun N, Grayson DR (2008). Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics 3: 74–80.
Shimabukuro M, Jinno Y, Fuke C, Okazaki Y (2009). Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct 2: 2.
Szyf M, McGowan P, Meaney MJ (2008). The social environment and the epigenome. Environ Mol Mutagen 49: 46–60.
Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9: 519–525.
Vandenberg RJ (1998). Molecular pharmacology and physiology of glutamate transporters in the central nervous system. Clin Exp Pharmacol Physiol 25: 393–400.
Weaver ICG, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR et al (2004). Epigenetic programming by maternal behavior. Nat Neurosci 7: 847–854.
Wilkinson MB, Xiao G, Kumar A, LaPlant Q, Renthal W, Sikder D et al (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 29: 7820–7832.
Wu JY, Niu FN, Huang R, Xu Y (2008a). Enhancement of glutamate uptake in 1-Methyl-4-Phenylpyridinium-treated astrocytes by Trichostatin A. Neuroreport 19: 1209–1212.
Wu LP, Wang X, Li L, Zhao Y, Lu SL, Yu Y et al (2008b). Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol 28: 3219–3235.
Wu XF, Chen PS, Dallas S, Wilson B, Block ML, Wang CC et al (2008c). Histone deacetylase inhibitors up-regulate astrocyte GDNF and bdnf gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11: 1123–1134.
Yamauchi J, Miyamoto Y, Murabe M, Fujiwara Y, Sanbe A, Fujita Y et al (2007). Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 Neuroblastoma cells. Exp Cell Res 313: 1886–1896.
Yang AS, Estecio MRH, Doshi K, Kondo Y, Tajara EH, Issa JPJ (2004). A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32: e38.
Zschocke J, Allritz C, Engele J, Rein T (2007). DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells. Glia 55: 663–674.
Zschocke J, Bayatti N, Clement AM, Witan H, Figiel M, Engele J et al (2005). Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem 280: 34924–34932.
Acknowledgements
This study was in part supported by the NARSAD Young Investigator Award and by the Horst Kübler foundation. We are grateful to Barbara Berning for excellent technical support. We thank T. Jenuwein for generously providing methyl-histone antibodies.
Author information
Authors and Affiliations
Corresponding author
Additional information
DISCLOSURE
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)
Supplementary information
Rights and permissions
About this article
Cite this article
Perisic, T., Zimmermann, N., Kirmeier, T. et al. Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes. Neuropsychopharmacol 35, 792–805 (2010). https://doi.org/10.1038/npp.2009.188
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2009.188
Keywords
This article is cited by
-
Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity
Molecular Psychiatry (2022)
-
Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
Journal of Neuroinflammation (2021)
-
Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy
CNS Drugs (2020)
-
The Effect of Chronic Mild Stress and Venlafaxine on the Expression and Methylation Levels of Genes Involved in the Tryptophan Catabolites Pathway in the Blood and Brain Structures of Rats
Journal of Molecular Neuroscience (2020)
-
Drugging the pain epigenome
Nature Reviews Neurology (2017)
